Our Singular Mission: Defeating COVID-19

Vaxxinity, a division of United Biomedical, is responding to the COVID-19 breakout in a manner that is consistent with our values by following the science and putting diagnostics and solutions-thinking at the center of our approach. Our priority is to stay on the front lines to safeguard the health and well-being of our communities.

As such, Vaxxinity is developing the first Multitope Peptide-Based Vaccine that has shown promising efficacy in animals and is based on a commercially proven, safe and scalable vaccine platform. We are entering human trials later this summer.

Peter's Role: Co-Founder and Vice Chairman